Browse the complete record of transactions filed by Caligan Partners LP. Director active across 2 companies, notably Standard Biotools INC.. Aggregated, 9 reports have been logged. Breakdown: 9 buys · 0 sell. Total volume traded: €11.7m. History available since 6 April 2022. The latest transaction was disclosed on 13 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 9 total
100,000 shares @ US$1.70 0.017% mcap 6.0% of flow Common Stock, $0.001 par value per share ("Common Stock") SEC:0000902664-22-003296:0
Ideal exit: 10 Mar 2023 (T+270) 200,000 shares @ US$1.92 0.036% mcap 13.1% of flow Common Stock, $0.001 par value per share ("Common Stock") SEC:0000902664-22-003177:0
Ideal exit: 27 Feb 2023 (T+270) 79,400 shares @ US$3.40 0.0050% mcap 2.8% of flow Common Stock, $0.001 par value per share ("Common Stock") SEC:0000902664-22-003105:0
Ideal exit: 19 Feb 2023 (T+270) 59,700 shares @ US$5.99 0.0067% mcap 3.8% of flow Common Stock, $0.001 par value per share ("Common Stock") SEC:0000902664-22-003037:0
Ideal exit: 11 Feb 2023 (T+270) 463,350 shares @ US$2.90 0.13% mcap 46.6% of flow Common Stock, $0.001 par value per share (Common Stock) SEC:0000902664-22-002849:0
Ideal exit: 31 Jan 2023 (T+270) 27,600 shares @ US$2.40 0.0064% mcap 2.3% of flow Common Stock, $0.001 par value per share ("Common Stock") SEC:0000902664-22-002740:0
Ideal exit: 23 Jan 2023 (T+270) 1,764,705 shares @ US$5.10 0.16% mcap 93.4% of flow Common Stock, $0.001 par value per share SEC:0000902664-22-002594:0
Ideal exit: 13 Jan 2023 (T+270) 145,000 shares @ US$3.87 0.052% mcap 18.9% of flow Common Stock, $0.001 par value per share ("Common Stock") SEC:0000902664-22-002542:0
Ideal exit: 6 Jan 2023 (T+270) 109,573 shares @ US$3.60 0.037% mcap 13.2% of flow Common Stock, $0.001 par value per share ("Common Stock") SEC:0000902664-22-002486:0
Ideal exit: 1 Jan 2023 (T+270) About Caligan Partners LP Caligan Partners LP is a director and insider at Standard Biotools INC. and Liquidia Corp.